These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging. Cherki M, Berrougui H, Isabelle M, Cloutier M, Koumbadinga GA, Khalil A. Exp Gerontol; 2007 Aug; 42(8):815-24. PubMed ID: 17532162 [Abstract] [Full Text] [Related]
13. Paraoxonase 1 activity and level of antibodies directed against oxidized low density lipoproteins in a group of an elderly population in Poland - PolSenior study. Bednarska-Makaruk M, Rodo M, Szirkowiec W, Mossakowska M, Puzianowska-Kuźnicka M, Skalska A, Zdrojewski T, Ryglewicz D, Wehr H. Arch Gerontol Geriatr; 2015 Aug; 60(1):153-61. PubMed ID: 25459919 [Abstract] [Full Text] [Related]
14. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes. Rosenblat M, Karry R, Aviram M. Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851 [Abstract] [Full Text] [Related]
15. Assessment of paraoxonase activity and lipid peroxidation levels in diabetic and senile subjects suffering from cataract. Hashim Z, Zarina S. Clin Biochem; 2007 Jun; 40(9-10):705-9. PubMed ID: 17466963 [Abstract] [Full Text] [Related]